SIRT1 and glioma: More importantly, downregulating hsa_circ_0076248 could remarkably promote the TMZ chemotherapy sensitivity, block the cell cycle, depress the proliferation in vitro and in vivo, suppress glioma cell invasion, and upregulate the expression of SIRT1, while miR‐181a inhibitor could reverse the effect.